Literature DB >> 12869474

Comparing cannabis with tobacco: those who start taking cannabis young have the greatest problems.

C Heather Ashton.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12869474      PMCID： PMC1126529          DOI： 10.1136/bmj.327.7407.165-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  One year follow-up of cannabis dependence among long-term users in Sydney, Australia.

Authors:  W Swift; W Hall; J Copeland
Journal:  Drug Alcohol Depend       Date:  2000-06-01       Impact factor: 4.492

2.  Mental health of teenagers who use cannabis. Results of an Australian survey.

Authors:  Joseph M Rey; Michael G Sawyer; Beverley Raphael; George C Patton; Michael Lynskey
Journal:  Br J Psychiatry       Date:  2002-03       Impact factor: 9.319

3.  Cannabis use and psychosocial adjustment in adolescence and young adulthood.

Authors:  David M Fergusson; L John Horwood; Nicola Swain-Campbell
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

4.  Comparing cannabis with tobacco.

Authors:  John A Henry; William L G Oldfield; Onn Min Kon
Journal:  BMJ       Date:  2003-05-03

5.  Cannabis use and dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing.

Authors:  W Swift; W Hall; M Teesson
Journal:  Addiction       Date:  2001-05       Impact factor: 6.526
  5 in total
  2 in total

1.  Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.

Authors:  Colm M P O'Tuathaigh; Magdalena Hryniewiecka; Aine Behan; Orna Tighe; Catherine Coughlan; Lieve Desbonnet; Mary Cannon; Maria Karayiorgou; Joseph A Gogos; David R Cotter; John L Waddington
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

2.  Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice.

Authors:  A Busquets-Garcia; E Soria-Gómez; B Redon; Y Mackenbach; M Vallée; F Chaouloff; M Varilh; G Ferreira; P-V Piazza; G Marsicano
Journal:  Mol Psychiatry       Date:  2017-02-21       Impact factor: 15.992
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.